Pacira Pharmaceuticals (PCRX) Posts Q4 Loss of 50c/Share

March 7, 2013 6:34 AM

Pacira Pharmaceuticals (NASDAQ: PCRX) reported Q4 EPS of ($0.50), $0.08 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found